lamivudine has been researched along with T-Cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacq, Y; Baty, G; de Muret, A; Dubois, F; Negreanu, L | 1 |
| Fujimoto, H; Fukutake, K; Funato, K; Hashimoto, Y; Yotsumoto, M | 1 |
| Chen, TY; Lee, YC; Su, WC; Tsao, CJ; Young, KC | 1 |
3 other study(ies) available for lamivudine and T-Cell Lymphoma
| Article | Year |
|---|---|
Hepatitis B virus reactivation after a resolutive acute hepatitis leading to a diagnosis of T cell lymphoma.
Topics: Aged; Antiviral Agents; DNA, Viral; Fatal Outcome; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Recurrence; Remission, Spontaneous | 2009 |
Central nervous system T-cell lymphoma in acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Brain; Central Nervous System Neoplasms; Humans; Lamivudine; Lymphoma, T-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Pyrrolidinones; Raltegravir Potassium; Stavudine; Treatment Outcome | 2010 |
Emergence of YMDD mutant hepatitis B virus after allogeneic stem cell transplantation from a HBsAG-positive donor during lamivudine prophylaxis.
Topics: Antibodies, Viral; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, T-Cell; Mutation; Premedication; Reverse Transcriptase Inhibitors; Tissue Donors; Transplantation, Homologous | 2004 |